Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza in Birds”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01258062
What this trial is testing

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

Who this might be right for
Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
Alachua Government Services, Inc. 7
Early research (Phase 1)Study completedNCT00755703
What this trial is testing

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Who this might be right for
Influenza A Subtype H5N1 Infection
Altimmune, Inc. 48
Early research (Phase 1)Study completedNCT02480101
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Who this might be right for
Influenza
Research Institute of Influenza, Russia 40
Testing effectiveness (Phase 2)Study completedNCT03283319
What this trial is testing

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza, Human
Biomedical Advanced Research and Development Authority 366
Not applicableStudy completedNCT00311727
What this trial is testing

Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 339
Testing effectiveness (Phase 2)Study completedNCT00914771
What this trial is testing

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 722
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00402649
What this trial is testing

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT00310206
What this trial is testing

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT01250795
What this trial is testing

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

Who this might be right for
Healthy
Fraunhofer, Center for Molecular Biotechnology 100
Early research (Phase 1)Study completedNCT02957656
What this trial is testing

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 53
Testing effectiveness (Phase 2)Study completedNCT00530660
What this trial is testing

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Who this might be right for
Influenza
Alachua Government Services, Inc. 141
Not applicableWithdrawnNCT00640302
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Not applicableStudy completedNCT02743676
What this trial is testing

A Retrospective, Observational Registry of Participants With Avian Influenza Infection

Who this might be right for
Influenza
Hoffmann-La Roche 648
Early research (Phase 1)Study completedNCT00457509
What this trial is testing

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 251
Early research (Phase 1)Study completedNCT01443936
What this trial is testing

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT03497845
What this trial is testing

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza A Virus, H5N1 Subtype
Biomedical Advanced Research and Development Authority 720
Early research (Phase 1)Study completedNCT01142362
What this trial is testing

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Who this might be right for
Healthy
Inovio Pharmaceuticals 32
Early research (Phase 1)Study completedNCT01317758
What this trial is testing

H5N1 Mix and Match With AS03

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 245
Testing effectiveness (Phase 2)Study completedNCT02921997
What this trial is testing

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Who this might be right for
Avian InfluenzaH1N1 InfluenzaInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Next Page